Pacira BioSciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	848	840	1,417	1,658	2,357	2,125
Market Cap Growth	-29.38%	-40.72%	-14.49%	-29.67%	10.89%	26.16%
Enterprise Value	1,000	1,024	1,739	2,119	2,234	2,129
Last Close Price	19.50	18.80	30.20	36.20	54.50	47.80
PE Ratio	46.41	-	37.35	111.35	63.85	17.86
PS Ratio	1.39	1.24	2.32	2.66	4.95	6.05
PB Ratio	1.37	1.12	1.80	2.29	3.67	4.20
P/TBV Ratio	3.07	2.47	7.01	24.87	-	6.14
P/FCF Ratio	8.01	4.87	11.23	15.38	33.57	66.27
P/OCF Ratio	7.03	4.59	10.13	12.19	21.32	33.75
EV/Sales Ratio	1.64	1.51	2.85	3.40	4.69	6.06
EV/EBITDA Ratio	7.10	6.01	11.80	14.91	21.45	36.46
EV/EBIT Ratio	18.08	10.87	22.01	31.93	28.26	50.55
EV/FCF Ratio	9.44	5.93	13.78	19.66	31.82	66.37
Debt / Equity Ratio	0.59	0.82	0.67	0.99	1.55	0.87
Debt / EBITDA Ratio	2.56	3.33	3.28	4.55	8.54	6.47
Debt / FCF Ratio	3.42	3.57	4.20	6.63	14.14	13.79
Net Debt / Equity Ratio	0.25	0.20	0.35	0.61	0.65	0.03
Net Debt / EBITDA Ratio	1.19	0.88	1.89	3.13	3.99	0.27
Net Debt / FCF Ratio	1.44	0.86	2.20	4.12	5.92	0.50
Asset Turnover	0.51	0.45	0.42	0.36	0.32	0.41
Inventory Turnover	1.83	2.19	2.60	2.92	2.40	2.88
Quick Ratio	3.38	1.93	3.95	2.63	1.45	2.28
Current Ratio	5.26	2.40	5.24	3.37	1.66	2.57
Return on Equity (ROE)	2.90%	-12.08%	5.10%	2.11%	6.22%	29.86%
Return on Assets (ROA)	2.89%	3.90%	3.35%	2.36%	3.36%	3.06%
Return on Invested Capital (ROIC)	3.61%	9.25%	4.89%	5.78%	7.27%	9.78%
Return on Capital Employed (ROCE)	5.50%	7.80%	5.90%	4.60%	5.80%	5.00%
Earnings Yield	2.15%	-11.45%	2.68%	0.90%	1.57%	5.60%
FCF Yield	12.48%	20.55%	8.90%	6.50%	2.98%	1.51%
Buyback Yield / Dilution	1.02%	11.03%	-11.69%	-1.99%	-4.46%	-5.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.